Effects of TRH, prolactin and TSH on cell proliferation in the intermediate lobe of the rat pituitary gland

1996 ◽  
Vol 148 (2) ◽  
pp. 193-196 ◽  
Author(s):  
T Pawełczyk ◽  
M Pawlikowski ◽  
J Kunert-Radek
Keyword(s):  
Cell Proliferation ◽  
Body Weight ◽  
Pituitary Gland ◽  
Anterior Lobe ◽  
Intermediate Lobe ◽  
Proliferating Cells ◽  
Rat Pituitary ◽  
Trh Analogues ◽  
Intermediate Pituitary Lobe ◽  
Significant Stimulatory Effect

Abstract The effect of TRH on cell proliferation in the anterior lobe of the pituitary is well known and documented. On the other hand, there are no data on the effects of TRH on the intermediate lobe of the pituitary gland. The aim of this study was to investigate the effect of TRH and its analogues (pGlu-His-Gly, pGlu-His-Gly-NH2) on cell proliferation in the intermediate pituitary lobe. The bromodeoxyuridine technique was used to detect the proliferating cells. It was found that TRH stimulated cell proliferation 24 h after a single injection at a dose of 100 μg/kg body weight. The TRH analogues did not exert any significant stimulatory effect either 12 h or 24 h after the injection. The second experiment was carried out to distinguish the probable mechanism of the action of TRH. The effects of TSH and prolactin (PRL) on intermediate lobe cell proliferation were examined. It was found that both PRL and TSH exerted a significant stimulatory effect 24 h after a single s.c. injection of PRL at a dose of 150 IU/kg body weight or TSH at a dose 20 IU/kg body weight. It therefore appears that the stimulatory effect of TRH on intermediate pituitary lobe cell proliferation is mediated by PRL and TSH. Journal of Endocrinology (1996) 148, 193–196

scholarly journals Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland.

1985 ◽  
Vol 101 (1) ◽  
pp. 305-311 ◽  
Author(s):  
P Kristensen ◽  
L S Nielsen ◽  
J Grøndahl-Hansen ◽  
P B Andresen ◽  
L I Larsson ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Pituitary Gland ◽  
Endocrine Cells ◽  
Large Population ◽  
Cell Types ◽  
Anterior Lobe ◽  
Tissue Type ◽  
Intermediate Lobe ◽  
Posterior Lobe ◽  
Rat Pituitary

We immunocytochemically stained rat pituitary glands using antibodies against plasminogen activators of the tissue type (t-PA) and the urokinase type (u-PA). A large population of endocrine cells in the anterior lobe of the gland displayed intense cytoplasmic immunoreactivity with anti-t-PA. In some areas of the intermediate lobe we found a weak staining, and we observed weakly staining granular structures in the posterior lobe. Controls included absorption of the antibodies with highly purified t-PA. In addition, SDS PAGE followed by immunoblotting of pituitary gland extracts revealed only one band with an electrophoretic mobility similar to that of t-PA when stained with anti-t-PA IgG. No u-PA immunoreactivity was detected in the rat pituitary gland. Sequential staining experiments using antibodies against growth hormone and t-PA demonstrated that the t-PA-immunoreactive cells constitute a large subpopulation of the growth hormone-containing cells. These findings represent the first direct evidence for the presence of t-PA in cell types other than endothelial cells in the intact normal organism. In this article we discuss the implications of the results for a possible role of t-PA in the posttranslational processing of prohormones.

The D-2 Dopamine Receptor in the Intermediate Lobe of the Rat Pituitary Gland

1983 ◽  
pp. 33-72 ◽  
Author(s):  
J. W. KEBABIAN ◽  
M. BEAULIEU ◽  
T. E. COTE ◽  
R. L. ESKAY ◽  
E. A. FREY ◽  
...  
Keyword(s):  
Pituitary Gland ◽  
Dopamine Receptor ◽  
Intermediate Lobe ◽  
Rat Pituitary

Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe

1994 ◽  
Vol 141 (3) ◽  
pp. 383-391 ◽  
Author(s):  
Y Arsenijevic ◽  
M Dubois-Dauphin ◽  
E Tribollet ◽  
M Manning ◽  
W H Sawyer ◽  
...  
Keyword(s):  
Pituitary Gland ◽  
Rat Liver ◽  
Arginine Vasopressin ◽  
Binding Sites ◽  
Anterior Lobe ◽  
Receptor Subtype ◽  
Lower Affinity ◽  
Corticotrophin Releasing Factor ◽  
Rat Pituitary ◽  
Acth Release

Abstract Arginine vasopressin (AVP) acts in the pituitary gland, in synergy with corticotrophin-releasing factor, to induce ACTH release in response to stressful stimuli. Pituitary AVP receptors in the rat are coupled to phospholipase C, as are the so-called V1-type AVP receptors. The present study examined [3H]AVP binding in membranes prepared from the anterior lobe of the pituitary gland of the pig. [3H]AVP, alone or in competition with analogues, bound to sites in the pig anterior lobe which are pharmacologically similar to those described previously by others in the rat pituitary gland. For comparison, the same competition studies were performed on membrane preparations from the rat liver which contain the classic V1-type AVP receptor. Pituitary and liver AVP-binding sites were dissimilar; both cyclic and linear V1 antagonists had, in general, a much lower affinity for pituitary AVP-binding sites than for those in the liver. Thus, Phaa-d-Tyr(Et)-Phe-Gln-Asn-Lys-Pro-Arg-NH2 (Phaa=phenylacetyl) has a 2500-fold greater affinity for the latter (negative logarithm of inhibition constant (pKi)=9·64) than for the former (pKi=6·22). One linear antagonist, Pa-d-Tyr-Phe-Val-Asn-Arg-Pro-Arg-Arg-NH2 (Pa=propionyl) had about equal affinities for liver and pituitary membranes (pKi=6·39 and 6·53 respectively). Another compound, Phaa-d-Tyr-Phe-Val-Asn-Arg-Pro-Arg-Arg-NH2 had the highest affinity found to date for binding to AVP sites in the pituitary (pKi=7·43). These findings suggest some ideas for the design of more potent and/or selective AVP analogues acting in the pituitary gland. Journal of Endocrinology (1994) 141, 383–391

Bromocriptine-Induced Changes in the Biochemistry, Physiology, and Histology of the Intermediate Lobe of the Rat Pituitary Gland

Endocrinology ◽  
1984 ◽  
Vol 114 (5) ◽  
pp. 1871-1884 ◽  
Author(s):  
M. BEAULIEU ◽  
M. E. GOLDMAN ◽  
K. MIYAZAKI ◽  
E. A. FREY ◽  
R. L. ESKAY ◽  
...  
Keyword(s):  
Pituitary Gland ◽  
Intermediate Lobe ◽  
Rat Pituitary ◽  
Induced Changes

Interleukin-1β stimulates cell proliferation in the intermediate lobe of the rat pituitary gland

1994 ◽  
Vol 140 (3) ◽  
pp. 337-341 ◽  
Author(s):  
H Stępień ◽  
G Żerek-Mełen ◽  
S Mucha ◽  
K Winczyk ◽  
J Fryczak
Keyword(s):  
Cell Proliferation ◽  
Cell Growth ◽  
Pituitary Gland ◽  
Molecular Forms ◽  
Brdu Incorporation ◽  
Immunocytochemical Staining ◽  
Pars Intermedia ◽  
Intermediate Lobe ◽  
Intermediate Cell ◽  
Receptor Antibody

Abstract Interleukin-1 (IL-1) is a multifunctional monokine which possesses an impressive array of diverse actions relating to the function of the immune system. IL-1 is present and formed locally in the brain as demonstrated by biochemical and immunocytochemical methods. Various immunomodulatory and neuroendocrine effects of IL-1 have been reported, including induction of several morphological changes in the endocrine cells of experimental animals and humans. IL-1 is present in two molecular forms (IL-1α and IL-1β) that activate specific receptors for IL-1. In the present study we investigated the possible effect of recombinant human IL-1α and IL-1β and recently cloned anti-human IL-1 receptor antibody (M10) on cell proliferation in the anterior and the intermediate lobe of the pituitary gland of the rat. In vivo labelling with bromodeoxyuridine (BrdU) and immunocytochemical staining with anti-BrdU monoclonal antibody were used as a sensitive index of cell proliferation. IL-1β was found to stimulate dose-dependently (0·1–10 μg/kg body weight) incorporation of BrdU into pituitary intermediate cell nuclei, and positive correlation between the tested doses of IL-1β and BrdU-labelling index was noted (r=0·89; P<0·01). This IL-1β-induced stimulation of pituitary pars intermedia cell proliferation was receptor specific, since stimulation was blocked by anti-IL-1 receptor antibody. On the other hand, recombinant human IL-1α did not affect BrdU incorporation and the proliferation of pituitary pars intermedia cells. In addition, neither of the cytokines tested in the same experimental conditions showed any effect on the cell growth of the pituitary pars anterior. These results suggest that IL-1β may be involved in the regulation of the cell growth of the pituitary intermediate lobe in rats. Journal of Endocrinology (1994) 140, 337–341

Sign in / Sign up

Export Citation Format

Share Document